Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Adult Antiretroviral Therapy"'
Autor:
Davey M. Smith, Susan J. Little, Douglas D. Richman, Sara Gianella, Josué Pérez-Santiago, Antoine Chaillon, Parris Jordan, Joel O. Wertheim, Caroline Ignacio, Steven M. Lada, Maile Y. Karris, Sanjay Mehta
Publikováno v:
Journal of virology, vol 92, iss 3
Chaillon, Antoine; Gianella, Sara; Lada, Steven M; Perez-Santiago, Josué; Jordan, Parris; Ignacio, Caroline; et al.(2018). Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.. Journal of virology, 92(3). doi: 10.1128/JVI.01589-17. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/2dz5q4q8
Chaillon, Antoine; Gianella, Sara; Lada, Steven M; Perez-Santiago, Josué; Jordan, Parris; Ignacio, Caroline; et al.(2018). Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.. Journal of virology, 92(3). doi: 10.1128/JVI.01589-17. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/2dz5q4q8
Residual viremia is common during antiretroviral therapy (ART) and could be caused by ongoing low-level virus replication or by release of viral particles from infected cells. ART intensification should impact ongoing viral propagation but not virion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5db9c6ca94addc5ddb77c1d14d6fc0
https://escholarship.org/uc/item/2dz5q4q8
https://escholarship.org/uc/item/2dz5q4q8
Autor:
Masato Nakazawa, Davey M. Smith, Michelli F. Oliveira, Christy M. Anderson, Susan J. Little, Michael L. Freeman, Sara Gianella
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 63, iss 11
Smith, Davey M; Nakazawa, Masato; Freeman, Michael L; Anderson, Christy M; Oliveira, Michelli F; Little, Susan J; et al.(2016). Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63(11), 1517-1524. doi: 10.1093/cid/ciw612. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/2f98s843
Smith, Davey M; Nakazawa, Masato; Freeman, Michael L; Anderson, Christy M; Oliveira, Michelli F; Little, Susan J; et al.(2016). Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63(11), 1517-1524. doi: 10.1093/cid/ciw612. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/2f98s843
Author(s): Smith, Davey M; Nakazawa, Masato; Freeman, Michael L; Anderson, Christy M; Oliveira, Michelli F; Little, Susan J; Gianella, Sara | Abstract: Background A low CD4/CD8 ratio in human immunodeficiency virus (HIV)-infected individuals is assoc
Autor:
Michael P. Dubé, Sara Gianella, Eric S. Daar, Marta Massanella, Davey M. Smith, Michelli F. Oliveira, Josué Pérez-Santiago, Rachel D. Schrier, Richard Haubrich, Sheldon R. Morris, Constance A. Benson, Jennifer M. Dan, Susan J. Little, Douglas D. Richman
Publikováno v:
Scientific reports, vol 5, iss 1
Scientific Reports
Massanella, Marta; Gianella, Sara; Schrier, Rachel; Dan, Jennifer M; Pérez-Santiago, Josué; Oliveira, Michelli F; et al.(2015). Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy.. Scientific reports, 5(1), 13179. doi: 10.1038/srep13179. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/93c2t8fm
Scientific Reports
Massanella, Marta; Gianella, Sara; Schrier, Rachel; Dan, Jennifer M; Pérez-Santiago, Josué; Oliveira, Michelli F; et al.(2015). Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy.. Scientific reports, 5(1), 13179. doi: 10.1038/srep13179. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/93c2t8fm
We investigated the associations between methamphetamine (meth) use, immune function and the dynamics of HIV and cytomegalovirus [CMV] in the blood and genital tract of HIV-infected ART-suppressed subjects. Self-reported meth use was associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4229bc9c891443928737c56b4426f27c
https://escholarship.org/uc/item/93c2t8fm
https://escholarship.org/uc/item/93c2t8fm
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Walter Grosso Marra, Andrea Calcagno, Pierluigi Omedè, Filippo Sciuto, Claudio Moretti, Giuseppe Biondi-Zoccai, Giorgio Quadri, Fabrizio D'Ascenzo, Simone Frea, Giacomo Frati, Davide Castagno, Fiorenzo Gaita, Stefano Bonora, Enrico Cerrato, Davide Giacomo Presutti
Publikováno v:
European Heart Journal. 34:1432-1436
Aims Human immunodeficiency virus infection (HIV) has been associated with cardiac dysfunction that, if present, can negatively affect morbidity and mortality of HIV-infected patients. Unfortunately, many of the studies on this topic were performed b
Publikováno v:
Tanzania Medical Journal; Vol 27, No 1 (2015)
Background: Guidelines for the treatment of HIV recommend the use of immunological and clinical criteria for treatment monitoring in resource limited settings. Data on the magnitude of immunological treatment failure in sub-Saharan Africa is scarce.
Autor:
Gian Piero Guerrini, Mario Spaggiari, F. Di Benedetto, Rosa Maria Iemmolo, Roberto Ballarin, Giorgio Enrico Gerunda, Giovanni Guaraldi, M.G. De Blasiis, N. De Ruvo, S. Di Sandro, Nazareno Smerieri, Roberto Montalti, M. Berretta
Publikováno v:
Transplantation Proceedings. 40:1965-1971
Highly active antiretroviral therapy (HAART) has been able to improve the immune system function and survival of HIV patients with a consequent increase in the number of HIV patients affected by end-stage liver disease (ESLD). Between June 2003 and O
Autor:
Sara Gianella, Bernard Hirschel, Andri Rauch, Matthias Cavassini, Enos Bernasconi, Manuel Battegay, Barbara Niederoest, Viktor von Wyl, Beda Joos, Huldrych F. Günthard, Herbert Kuster, Swiss Hiv Cohort Study-SHCS, Marek Fischer, Pietro Vernazza, Rainer Weber
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27463 (2011)
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; et al.(2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.. PloS one, 6(11), e27463. doi: 10.1371/journal.pone.0027463. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/6c70z38x
Plos One, vol. 6, no. 11, pp. e27463
PloS one, vol 6, iss 11
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Rauch, Andri; Hirschel, Bernard; Vernazza, Pietro; Weber, Rainer; Joos, Beda; Günthard, Huldrych F; Swiss HIV Cohort Study-SHCS, (2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS ONE, 6(11), e27463. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027463
PLoS ONE
PloS one
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; et al.(2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.. PloS one, 6(11), e27463. doi: 10.1371/journal.pone.0027463. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/6c70z38x
Plos One, vol. 6, no. 11, pp. e27463
PloS one, vol 6, iss 11
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Rauch, Andri; Hirschel, Bernard; Vernazza, Pietro; Weber, Rainer; Joos, Beda; Günthard, Huldrych F; Swiss HIV Cohort Study-SHCS, (2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS ONE, 6(11), e27463. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027463
PLoS ONE
PloS one
Background: Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated. Methods: The evolution of plasma HIV-RNA (432 measurements) and cell-associated HIV-DNA (325 measurements) after cessat
Autor:
C. Cometto, Silvia Fontana, Antonio D'Avolio, D. Aguilar, G. Di Perri, Andrea Calcagno, Stefano Bonora, A. Maiello, Anna Lucchini, I. Dal Conte, D. Gonzalez de Requena
To evaluate whether the addition of enfuvirtide to standard highly active antiretroviral therapy (HAART) could confer immunovirological benefits in human immunodeficiency virus (HIV)-infected very late presenters. The current study is an open compara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe511c43e8d82f4a8a0c4005b7bc9de1
http://hdl.handle.net/2318/116627
http://hdl.handle.net/2318/116627
Autor:
Rotger, M, Taffe, P, Bleiber, G, Gunthard, HF, Furrer, H, Vernazza, P, Drechsler, H, Bernasconi, E, Rickenbach, M, Telenti, A, Swiss, HIV Cohort Study
Publikováno v:
Journal of Infectious Diseases, vol. 192, no. 8, pp. 1381-6
Rotger, M; Taffe, P; Bleiber, G; Gunthard, HF; Furrer, H; Vernazza, P; Drechsler, H; Bernasconi, E; Rickenbach, M; Telenti, A; Swiss, HIV Cohort Study (2005). Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. Journal of infectious diseases, 192(8), pp. 1381-6. Cary, N.C.: The University of Chicago Press 10.1086/466531
Rotger, M; Taffe, P; Bleiber, G; Gunthard, HF; Furrer, H; Vernazza, P; Drechsler, H; Bernasconi, E; Rickenbach, M; Telenti, A; Swiss, HIV Cohort Study (2005). Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. Journal of infectious diseases, 192(8), pp. 1381-6. Cary, N.C.: The University of Chicago Press 10.1086/466531
BACKGROUND: Unconjugated hyperbilirubinemia results from Gilbert syndrome and from antiretroviral therapy (ART) containing protease inhibitors. An understanding of the interaction between genetic predisposition and ART may help to identify individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1006fd9ea4373950097f307dfb11f357
https://serval.unil.ch/notice/serval:BIB_50D5FB6BE899
https://serval.unil.ch/notice/serval:BIB_50D5FB6BE899